Rocket Pharmaceuticals Inc
RCKT
Market Cap$854.11M
Close$
$1.46
79.3% downside
Current Fair Value
79.3% downsideOvervalued by 79.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $854.11 Million |
|---|---|
| Enterprise Value | $715.97 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.73 |
| Beta | 1 |
| Outstanding Shares | 97,530,032 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.02 |
|---|---|
| PEG | -38.77 |
| Price to Sales | - |
| Price to Book Ratio | 1.76 |
| Enterprise Value to Revenue | 69.43 |
| Enterprise Value to EBIT | -2.65 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Rocket Pharmaceuticals Inc
151 employees
CEO: Gaurav Shah